Cingulate Inc. (CING) vs Fractyl Health, Inc. (GUTS)

A side-by-side comparison of Cingulate Inc. and Fractyl Health, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

CING

Cingulate Inc.

$66M

$4.89HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT

GUTS

Fractyl Health, Inc.

$60M

$4.57HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT

Total return — CING vs GUTS

growth of $100 · dividends reinvested · last 3y

CING -70.2% (-33.2%/yr)GUTS -97.0% (-69.1%/yr)CING compounded faster over this window

Log scale — wide-divergence pair

CING GUTS

CING vs GUTS: by the numbers

•CING is the larger company ($66M vs $60M market cap).

Metrics side by side

Valuation

Metric	CING	GUTS
P/B ratio	2.81	N/A
EV / EBITDA	0.22	N/A

Profitability

Metric	CING	GUTS
Gross margin	0.00%	0.00%
Operating margin	0.00%	0.00%
Net margin	0.00%	0.00%
ROE	-122.71%	N/A
ROIC	-83.74%	-129.67%

Go deeper

Full CING analysis Full GUTS analysis Interactive comparison tool

Dig into the metrics

Cingulate ROE Fractyl Health ROE Cingulate operating margin Fractyl Health operating margin Cingulate revenue growth Fractyl Health revenue growth Cingulate free cash flow Fractyl Health free cash flow

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.